Bamco Inc. NY acquired a new stake in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 313,262 shares of the business services provider’s stock, valued at approximately $25,904,000. Bamco Inc. NY owned about 0.62% of Exponent at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in EXPO. Pacer Advisors Inc. boosted its holdings in Exponent by 24.4% in the fourth quarter. Pacer Advisors Inc. now owns 7,608 shares of the business services provider’s stock valued at $670,000 after purchasing an additional 1,491 shares during the last quarter. Assenagon Asset Management S.A. raised its position in shares of Exponent by 261.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 56,510 shares of the business services provider’s stock worth $4,975,000 after acquiring an additional 40,886 shares during the period. Fenimore Asset Management Inc. raised its position in shares of Exponent by 62.8% in the fourth quarter. Fenimore Asset Management Inc. now owns 172,868 shares of the business services provider’s stock worth $15,219,000 after acquiring an additional 66,664 shares during the period. Trust Point Inc. acquired a new position in shares of Exponent in the fourth quarter worth about $770,000. Finally, Asset Management One Co. Ltd. acquired a new position in shares of Exponent in the fourth quarter worth about $4,340,000. 92.37% of the stock is owned by hedge funds and other institutional investors.
Exponent Trading Down 0.6 %
EXPO stock traded down $0.62 during mid-day trading on Friday, reaching $105.45. The company’s stock had a trading volume of 359,737 shares, compared to its average volume of 190,804. The stock has a market cap of $5.35 billion, a PE ratio of 53.26 and a beta of 0.65. Exponent, Inc. has a fifty-two week low of $64.61 and a fifty-two week high of $108.00. The company’s 50 day moving average is $97.16 and its two-hundred day moving average is $88.42.
Exponent Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, September 20th. Investors of record on Friday, September 6th will be paid a dividend of $0.28 per share. The ex-dividend date is Friday, September 6th. This represents a $1.12 annualized dividend and a yield of 1.06%. Exponent’s dividend payout ratio is currently 56.57%.
Analyst Ratings Changes
Separately, Truist Financial reiterated a “buy” rating and issued a $120.00 price objective (up previously from $100.00) on shares of Exponent in a research report on Friday.
Read Our Latest Stock Analysis on Exponent
Insider Buying and Selling
In other Exponent news, VP Bradley A. James sold 3,528 shares of the firm’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $95.00, for a total transaction of $335,160.00. Following the transaction, the vice president now directly owns 2,030 shares of the company’s stock, valued at approximately $192,850. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, VP Bradley A. James sold 3,528 shares of Exponent stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $95.00, for a total value of $335,160.00. Following the sale, the vice president now owns 2,030 shares of the company’s stock, valued at $192,850. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Eric Guyer sold 1,650 shares of the business’s stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total transaction of $152,757.00. Following the sale, the insider now directly owns 1,846 shares in the company, valued at approximately $170,902.68. The disclosure for this sale can be found here. Insiders have sold 50,067 shares of company stock worth $4,734,995 in the last ninety days. 2.10% of the stock is owned by corporate insiders.
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
- Five stocks we like better than Exponent
- Health Care Stocks Explained: Why You Might Want to Invest
- Is Crypto Cool Again? What Stocks You Should Be Watching
- How to Capture the Benefits of Dividend Increases
- Why Call Options Volume for These 2 Stocks Spiked Together
- Best Aerospace Stocks Investing
- MarketBeat Week in Review – 7/22 – 7/26
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.